ANGLE Technology Ventures

ANGLE Technology Ventures appears on its own site as ANGLE, a company built around the Parsortix system, a device for capturing rare cells from blood. The technology works on whole blood samples taken from a simple blood test, without first removing red blood cells, which the company says keeps cell loss low.

What ANGLE Technology Ventures does

• Parsortix PC1 system: A clinical-model instrument for harvesting circulating tumour cells; it is labelled for research use only.
• CTC laboratory services: Enumeration of epithelial and mesenchymal circulating tumour cell populations.
• Gene expression profiling: Multiplex profiling of captured cell populations.
• PD-L1 analysis and custom assays: Analysis of cell populations, plus assays built to order.
• Translational research support: Work in women's health, including ovarian and breast cancer, men's health such as prostate cancer, and low-volume samples for animal models.

Customers and markets

Researchers and clinical scientists working on precision medicine. The company also publishes investor pages, showing it is a listed business.

Key facts

• Product: Parsortix PC1 Clinical System
• Use status: For research use only, not for clinical diagnostic procedures
• Market: Positions itself in the liquid biopsy field